Form 4: Zimmer Biomet Executive Sang Yi Reports Stock Transactions
SEC Form 4 Filing
Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported the acquisition and disposal of common stock and restricted stock units on March 1, 2024.
Summary
- On March 1, 2024, Sang Yi, Group President, Asia Pacific at Zimmer Biomet Holdings, Inc., reported transactions involving the company's stock.
- These transactions included the acquisition of 2,052 shares of common stock at a price of $0 and the disposal of 15,814 shares of common stock.
- Yi also reported the acquisition of 2,052 restricted stock units, which convert to common stock, also on March 1, 2024.
- Following these transactions, Yi directly owns a certain amount of Zimmer Biomet Holdings, Inc. common stock.
Sentiment
Score: 5
Explanation: This is a neutral regulatory filing. It simply reports stock transactions by an executive and doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, as required by the SEC. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of the stock transactions (acquisition and disposal of common stock and restricted stock units). |
| 03/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.